Clinical Trial Update: Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating whether adding thalidomide to cetuximab with standard chemotherapy improves outcomes in left-sided colorectal cancer; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Thalidomide (thalidomide)

Snippet

Sponsor: Xinqiao Hospital of Chongqing | Conditions: Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer | Phase 2 | Status: RECRUITING